About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
Symbol
Name
ID
Npy1r
neuropeptide Y receptor Y1
MGI:104963
89 phenotypes from 7 alleles in 8 genetic backgrounds
Export: Excel File
Allelic Composition
Genetic Background
Annotated Term Reference
Npy1rtm1.1Ceva/Npy1rtm1.1Ceva
Tg(Camk2a-tTA)1Mmay/0
Tg(tetO-cre)LC1Bjd/0
involves: 129S1/Sv * 129X1/SvJ * BALB/c * C57BL/6 * SJL
decreased circulating leptin level J:180396
decreased epididymal fat pad weight J:180396
decreased locomotor activity J:180396
decreased subcutaneous adipose tissue amount J:180396
decreased total fat pad weight J:180396
increased anxiety-related response J:180396
increased circulating corticosterone level J:180396
slow postnatal weight gain J:180396
Npy1rtm1.1Wpg/Npy1rtm1.1Wpg
involves: 129X1/SvJ * C57BL/6
abnormal immune cell physiology J:118850
abnormal immune system organ morphology J:118850
abnormal immune system physiology J:118850
abnormal immunoglobulin level J:118850
abnormal inflammatory response J:118850
abnormal lymph node cell ratio J:118850
abnormal macrophage physiology J:118850
abnormal neuron differentiation J:92582
abnormal professional antigen presenting cell physiology J:118850
abnormal spleen morphology J:118850
abnormal splenic cell ratio J:118850
abnormal T cell activation J:118850
abnormal T cell number J:118850
abnormal T-helper 1 physiology J:118850
decreased B cell number J:118850
decreased CD8-positive, alpha-beta T cell number J:118850
decreased circulating interleukin-12 level J:118850
decreased circulating tumor necrosis factor level J:118850
decreased IgG2a level J:118850
decreased interferon-gamma secretion J:118850
decreased marginal zone B cell number J:118850
decreased mature B cell number J:118850
decreased susceptibility to type IV hypersensitivity reaction J:118850
decreased susceptibility to xenobiotic induced morbidity/mortality J:124729
decreased transitional stage B cell number J:118850
hyperactivity J:92440
increased aggression towards mice J:92440
increased CD4-positive, alpha-beta T cell number J:118850
increased CD8-positive, alpha-beta T cell number J:118850
increased IgA level J:118850
increased IgG2b level J:118850
increased IgM level J:118850
increased immunoglobulin level J:118850
increased litter size J:92440
increased single-positive T cell number J:118850
small spleen J:118850
Npy1rtm1.1Wpg/Npy1rtm1.1Wpg
involves: C57BL/6
abnormal olfactory sensory neuron morphology J:132859
abnormal postnatal subventricular zone morphology J:132859
abnormal rostral migratory stream morphology J:132859
decreased neuronal precursor cell number J:132859
Npy1rtm1Aka/Npy1rtm1Aka
involves: C57BL/6 * CBA
abnormal eating behavior J:60632
obese J:60632
Npy1rtm1Mnak/Npy1rtm1Mnak
involves: 129P2/OlaHsd * C57BL/6
normal behavior/neurological phenotype J:51684
decreased energy expenditure J:51684
impaired glucose tolerance J:51684
increased body weight J:51684
increased circulating insulin level J:51684
increased gonadal fat pad weight J:51684
increased retroperitoneal fat pad weight J:51684
Npy1rtm1Pern/Npy1rtm1Pern
Not Specified
abnormal righting response J:71826
Npy1rtm1Tped/Npy1rtm1Tped
B6.129P2-Npy1rtm1Tped
abnormal cardiovascular system physiology J:101870
abnormal glucose homeostasis J:102554
abnormal glycogen level J:102554
abnormal sympathetic system morphology J:101870
normal behavior/neurological phenotype J:108001
cardiac interstitial fibrosis J:101870
decreased exploration in new environment J:101870
decreased heart rate J:101870
hyperglycemia J:102554
impaired behavioral response to alcohol J:109207
increased adipocyte glucose uptake J:102554
increased alcohol consumption J:109207
increased circulating corticosterone level J:87424
increased circulating insulin level J:87424, J:102554
increased circulating leptin level J:87424
increased epididymal fat pad weight J:102554
increased percent body fat/body weight J:102554
increased retroperitoneal fat pad weight J:87424
obese J:87424
Npy1rtm1Tped/Npy1rtm1Tped
involves: 129P2/OlaHsd * C57BL/6
abnormal energy expenditure J:47972
abnormal vasoconstriction J:47972
decreased compensatory feeding amount J:47972
decreased food intake J:47972
decreased locomotor activity J:47972
decreased oxygen consumption J:47972
increased circulating free fatty acids level J:47972
increased circulating insulin level J:47972
increased circulating leptin level J:47972
increased total body fat amount J:47972
normal mortality/aging J:47972
obese J:47972
Npy1rtm1Wpg/Npy1rtm1Wpg
involves: 129X1/SvJ * C57BL/6
no abnormal phenotype detected J:92582
Npy1rtm1Wpg/Npy1rtm1Wpg
Tg(Col1a1-cre)2Bek/0
involves: CD-1
abnormal bone ossification J:170291
abnormal osteoblast physiology J:170291
increased bone mineral content J:170291
increased bone mineral density J:170291
increased bone strength J:170291
increased bone trabecula number J:170291
increased diameter of femur J:170291
increased trabecular bone thickness J:170291

Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
07/02/2024
MGI 6.13
The Jackson Laboratory